nach oben

Archives of Gynecology and Obstetrics

Erschienen in:

01.10.2009 | Review

Treatment of fibroids via uterine artery occlusion (uterine artery embolization and Doppler-guided uterine artery occlusion): potential role in today’s armamentarium

verfasst von: Andrew I. Brill

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

Uterine fibroids, the most common benign tumors of the female reproductive system, are the most common indication for hysterectomy. However, this procedure is not the ideal treatment for many women including those who desire to preserve their fertility or simply do not want to undergo surgery. New technologies and surgical innovation provide treatments that are less associated with morbidity such as uterine artery embolization, magnetic resonance imaging-guided focused ultrasound, and laparoscopic uterine artery occlusion. This manuscript will discuss the putative mechanism of action and clinical application of uterine artery occlusion using Doppler-guided Uterine Artery Occlusion, a new investigational treatment modality for uterine fibroids.

Keshavarz H, Hillis SD, Kieke BA, Marchbanks PA (2002) Hysterectomy surveillance—United States, 1994–1999. MMWR CDC Surveill Summ 51:1–8

Velebil P, Wingo PA, Xia Z, Wilcox LS, Peterson HB (1995) Rate of hospitalization for gynecologic disorders among reproductive-age women in the United States. Obstet Gynecol 86:764–769. doi:10.1016/0029-7844(95)00252-M PubMedCrossRef

Farquhar CM, Steiner CA (2002) Hysterectomy rates in the United States 1990–1997. Obstet Gynecol 99:229–234. doi:10.1016/S0029-7844(01)01723-9 PubMedCrossRef

Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM (2003) High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 188:100–107. doi:10.1067/mob.2003.99 PubMedCrossRef

Hartmann KE, Birnbaum H, Ben-Hamadi R, Wu EQ, Farrell MH, Spalding J, Stang P (2006) Annual costs associated with diagnosis of uterine leiomyomata. Obstet Gynecol 108:930–937PubMed

Frishman GN, Jurema MW (2005) Myomas and myomectomy. J Minim Invasive Gynecol 12:443–456. doi:10.1016/j.jmig.2005.05.023 PubMedCrossRef

Martin Chaves EB, Brum IS, Stoll J, Capp E, Corleta HE (2004) Insulin-like growth factor 1 receptor mRNA expression and autophosphorylation in human myometrium and leiomyoma. Gynecol Obstet Invest 57:210–213. doi:10.1159/000076690 PubMedCrossRef

Arici A, Sozen I (2000) Transforming growth factor-beta3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation. Fertil Steril 73:1006–1011. doi:10.1016/S0015-0282(00)00418-0 PubMedCrossRef

Luo X, Ding L, Xu J, Chegini N (2005) Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta. Endocrinology 146:1097–1118. doi:10.1210/en.2004-1377 PubMedCrossRef

10.

Shikora SA, Niloff JM, Bistrian BR, Forse RA, Blackburn GL (1991) Relationship between obesity and uterine leiomyomata. Nutrition 7:251–255PubMed

11.

Day Baird D, Dunson DB (2003) Why is parity protective for uterine fibroids? Epidemiology 14:247–250. doi:10.1097/00001648-200303000-00021 CrossRef

12.

Adamyan LV (2003) Minimally invasive surgery in gynecologic practice. Int J Gynaecol Obstet 82:347–355. doi:10.1016/S0020-7292(03)00216-9 PubMedCrossRef

13.

Falcone T, Bedaiwy MA (2002) Minimally invasive management of uterine fibroids. Curr Opin Obstet Gynecol 14:401–407. doi:10.1097/00001703-200208000-00007 PubMedCrossRef

14.

Common AA, Mocarski EJ, Kolin A, Pron G, Soucie J (2001) Therapeutic failure of uterine fibroid embolization caused by underlying leiomyosarcoma. J Vasc Interv Radiol 12:1449–1452. doi:10.1016/S1051-0443(07)61708-4 PubMedCrossRef

15.

Cramer SF, Marchetti C, Freedman J, Padela A (2000) Relationship of myoma cell size and menopausal status in small uterine leiomyomas. Arch Pathol Lab Med 124:1448–1453PubMed

16.

Carlson KJ, Miller BA, Fowler FJ Jr (1994) The Maine women’s health study: I. Outcomes of hysterectomy. Obstet Gynecol 83:556–565PubMedCrossRef

17.

Jacobson GF, Shaber RE, Armstrong MA, Hung YY (2007) Changes in rates of hysterectomy and uterine conserving procedures for treatment of uterine leiomyoma. Am J Obstet Gynecol 196:601.e1–601.e6CrossRef

18.

Doridot V, Dubuisson JB, Chapron C, Fauconnier A, Babaki-Fard K (2001) Recurrence of leiomyomata after laparoscopic myomectomy. J Am Assoc Gynecol Laparosc 8:495–500. doi:10.1016/S1074-3804(05)60610-X PubMedCrossRef

19.

Seracchioli R, Rossi S, Govoni F, Rossi E, Venturoli S, Bulletti C, Flamigni C (2000) Fertility and obstetric outcome after laparoscopic myomectomy of large myomata: a randomized comparison with abdominal myomectomy. Hum Reprod 15:2663–2668. doi:10.1093/humrep/15.12.2663 PubMedCrossRef

20.

Donnez J, Squifflet J, Polet R, Nisolle M (2000) Laparoscopic myolysis. Hum Reprod Update 6:609–613. doi:10.1093/humupd/6.6.609 PubMedCrossRef

21.

Nisolle M, Smets M, Malvaux V, Anaf V, Donnez J (1993) Laparoscopic myolysis with the Nd:YAG laser. J Gynecol Surg 9:95–99PubMedCrossRef

22.

Phillips DR, Nathanson HG, Milim SJ, Haselkorn JS (1996) Laparoscopic leiomyoma coagulation. J Am Assoc Gynecol Laparosc 3:S39

23.

Goldfarb HA (1999) Combining myoma coagulation with endometrial ablation/resection reduces subsequent surgery rates. JSLS 3:253–260PubMed

24.

Zupi E, Sbracia M, Marconi D, Munro MG (2006) Myolysis of uterine fibroids: is there a role? Clin Obstet Gynecol 49:821–833. doi:10.1097/01.grf.0000211961.91616.78 PubMedCrossRef

25.

Zupi E, Piredda A, Marconi D, Townsend D, Exacoustos C, Arduini D, Szabolcs B (2004) Directed laparoscopic cryomyolysis: a possible alternative to myomectomy and/or hysterectomy for symptomatic leiomyomas. Am J Obstet Gynecol 190:639–643. doi:10.1016/j.ajog.2003.10.687 PubMedCrossRef

26.

Zupi E, Marconi D, Sbracia M, Exacoustos C, Piredda A, Sorrenti G, Townsend D (2005) Directed laparoscopic cryomyolysis for symptomatic leiomyomata: one-year follow up. J Minim Invasive Gynecol 12:343–346. doi:10.1016/j.jmig.2005.05.011 PubMedCrossRef

27.

Parker WH (2007) Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril 87:725–736. doi:10.1016/j.fertnstert.2007.01.093 PubMedCrossRef

28.

ExAblate (2004) InSightec^® ExAblate^® 2000 System Magnetic Resonance guided Focused Ultrasound Surgery [prescribing information]

29.

Sharp HT (2006) Assessment of new technology in the treatment of idiopathic menorrhagia and uterine leiomyomata. Obstet Gynecol 108:990–1003PubMed

30.

Hindley J, Gedroyc WM, Regan L, Stewart E, Tempany C, Hynyen K, McDannold N, Inbar Y, Itzchak Y, Rabinovici J, Kim HS, Geschwind JF, Hesley G, Gostout B, Ehrenstein T, Hengst S, Sklair-Levy M, Shushan A, Jolesz F (2004) MRI guidance of focused ultrasound therapy of uterine fibroids: early results. AJR Am J Roentgenol 183:1713–1719PubMed

31.

Stewart EA, Rabinovici J, Tempany CM, Inbar Y, Regan L, Gostout B, Hesley G, Kim HS, Hengst S, Gedroyc WM (2006) Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril 85:22–29. doi:10.1016/j.fertnstert.2005.04.072 PubMedCrossRef

32.

Stewart EA, Gedroyc WM, Tempany CM, Quade BJ, Inbar Y, Ehrenstein T, Shushan A, Hindley JT, Goldin RD, David M, Sklair M, Rabinovici J (2003) Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique. Am J Obstet Gynecol 189:48–54. doi:10.1067/mob.2003.345 PubMedCrossRef

33.

Oliver JA Jr, Lance JS (1979) Selective embolization to control massive hemorrhage following pelvic surgery. Am J Obstet Gynecol 135:431–432PubMed

34.

Ravina JH, Herbreteau D, Ciraru-Vigneron N, Bouret JM, Houdart E, Aymard A, Merland JJ (1995) Arterial embolisation to treat uterine myomata. Lancet 346:671–672. doi:10.1016/S0140-6736(95)92282-2 PubMedCrossRef

35.

Kroencke TJ, Scheurig C, Kluner C, Taupitz M, Schnorr J, Hamm B (2006) Uterine fibroids: contrast-enhanced MR angiography to predict ovarian artery supply—initial experience. Radiology 241:181–189. doi:10.1148/radiol.2411051075 PubMedCrossRef

36.

Burbank F, Hutchins FL Jr (2000) Uterine artery occlusion by embolization or surgery for the treatment of fibroids: a unifying hypothesis-transient uterine ischemia. J Am Assoc Gynecol Laparosc 7(suppl 4):S1–S49. doi:10.1016/S1074-3804(05)60633-0 PubMed

37.

Scheurig C, Gauruder-Burmester A, Kluner C, Kurzeja R, Lembcke A, Zimmermann E, Hamm B, Kroencke T (2006) Uterine artery embolization for symptomatic fibroids: short-term versus mid-term changes in disease-specific symptoms, quality of life and magnetic resonance imaging results. Hum Reprod 21:3270–3277. doi:10.1093/humrep/del275 PubMedCrossRef

38.

Spies JB, Warren EH, Mathias SD, Walsh SM, Roth AR, Pentecost MJ (1999) Uterine fibroid embolization: measurement of health-related quality of life before and after therapy. J Vasc Interv Radiol 10:1293–1303. doi:10.1016/S1051-0443(99)70235-6 PubMedCrossRef

39.

Bucek RA, Puchner S, Lammer J (2006) Mid- and long-term quality-of-life assessment in patients undergoing uterine fibroid embolization. AJR Am J Roentgenol 186:877–882. doi:10.2214/AJR.04.1767 PubMedCrossRef

40.

Myers ER, Goodwin S, Landow W, Mauro M, Peterson E, Pron G, Spies JB, Worthington-Kirsch R (2005) Prospective data collection of a new procedure by a specialty society: the FIBROID registry. Obstet Gynecol 106:44–51PubMed

41.

Spies JB, Myers ER, Worthington-Kirsch R, Mulgund J, Goodwin S, Mauro M (2005) The FIBROID Registry: symptom and quality-of-life status 1 year after therapy. Obstet Gynecol 106:1309–1318PubMed

42.

Spies JB, Cooper JM, Worthington-Kirsch R, Lipman JC, Mills BB, Benenati JF (2004) Outcome of uterine embolization and hysterectomy for leiomyomas: results of a multicenter study. Am J Obstet Gynecol 191:22–31. doi:10.1016/j.ajog.2004.03.037 PubMedCrossRef

43.

Lefebvre GG, Vilos G, Asch M (2004) Uterine fibroid embolization (UFE). J Obstet Gynaecol Can 26:899–928PubMed

44.

Volkers NA, Hehenkamp WJ, Birnie E, Ankum WM, Reekers JA (2007) Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years’ outcome from the randomized EMMY trial. Am J Obstet Gynecol 196:519.e1–519.e11CrossRef

45.

Broder MS, Goodwin S, Chen G, Tang LJ, Costantino MM, Nguyen MH, Yegul TN, Erberich H (2002) Comparison of long-term outcomes of myomectomy and uterine artery embolization. Obstet Gynecol 100:864–868. doi:10.1016/S0029-7844(02)02182-8 PubMedCrossRef

46.

Siskin GP, Shlansky-Goldberg RD, Goodwin SC, Sterling K, Lipman JC, Nosher JL, Worthington-Kirsch RL, Chambers TP (2006) A prospective multicenter comparative study between myomectomy and uterine artery embolization with polyvinyl alcohol microspheres: long-term clinical outcomes in patients with symptomatic uterine fibroids. J Vasc Interv Radiol 17:1287–1295PubMedCrossRef

47.

Hehenkamp WJ, Volkers NA, Donderwinkel PFJ, de Blok S, Birnie E, Ankum WM, Reekers JA (2005) Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): peri- and postprocedural results from a randomized controlled trial. Am J Obstet Gynecol 193:1618–1629. doi:10.1016/j.ajog.2005.05.017 PubMedCrossRef

48.

Walker WJ, McDowell SJ (2006) Pregnancy after uterine artery embolization for leiomyomata: a series of 56 completed pregnancies. Am J Obstet Gynecol 195:1266–1271. doi:10.1016/j.ajog.2006.02.047 PubMedCrossRef

49.

Carpenter TT, Walker WJ (2005) Pregnancy following uterine artery embolisation for symptomatic fibroids: a series of 26 completed pregnancies. BJOG 112:321–325. doi:10.1111/j.1471-0528.2004.00414.x PubMedCrossRef

50.

American College of Obstetricians, Gynecologists (2004) Uterine artery embolization. ACOG Committee Opinion No. 293. Obstet Gynecol 103:403–404

51.

Pron G, Mocarski E, Bennett J, Vilos G, Common A, Vanderburgh L (2005) Pregnancy after uterine artery embolization for leiomyomata: the Ontario multicenter trial. Obstet Gynecol 105:67–76PubMed

52.

Goldberg J, Pereira L, Berghella V, Diamond J, Darai E, Seinera P, Seracchioli R (2004) Pregnancy outcomes after treatment for fibromyomata: uterine artery embolization versus laparoscopic myomectomy. Am J Obstet Gynecol 191:18–21. doi:10.1016/j.ajog.2004.01.046 PubMedCrossRef

53.

Holub Z, Mara M, Eim J (2007) Laparoscopic uterine artery occlusion versus uterine fibroid embolization. Int J Gynaecol Obstet 96:44–45. doi:10.1016/j.ijgo.2006.09.016 PubMedCrossRef

54.

Lichtinger M, Hallson L, Calvo P, Adeboyejo G (2002) Laparoscopic uterine artery occlusion for symptomatic leiomyomas. J Am Assoc Gynecol Laparosc 9:191–198. doi:10.1016/S1074-3804(05)60131-4 PubMedCrossRef

55.

Holub Z, Jabor A, Lukac J, Kliment L, Urbanek S (2004) Midterm follow-up study of laparoscopic dissection of uterine vessels for surgical treatment of symptomatic fibroids. Surg Endosc 18:1349–1353. doi:10.1007/s00464-003-9245-z PubMedCrossRef

56.

Holub Z, Eim J, Jabor A, Hendl A, Lukac J, Kliment L (2006) Complications and myoma recurrence after laparoscopic uterine artery occlusion for symptomatic myomas. J Obstet Gynaecol Res 32:55–62. doi:10.1111/j.1447-0756.2006.00351.x PubMedCrossRef

57.

Dickner SK, Cooper JM, Diaz D (2004) A nonincisional, Doppler-guided transvaginal approach to uterine artery identification and control of uterine perfusion. J Am Assoc Gynecol Laparosc 11:55–58. doi:10.1016/S1074-3804(05)60011-4 PubMedCrossRef

58.

Lichtinger M, Herbert S, Memmolo A (2005) Temporary, transvaginal occlusion of the uterine arteries: a feasibility and safety study. J Minim Invasive Gynecol 12:40–42. doi:10.1016/j.jmig.2004.12.020 PubMedCrossRef

59.

Vilos GA, Vilos EC, Romano W, Abu-Rafea B (2006) Temporary uterine artery occlusion for treatment of menorrhagia and uterine fibroids using an incisionless Doppler-guided transvaginal clamp: case report. Hum Reprod 21:269–271. doi:10.1093/humrep/dei299 PubMedCrossRef

60.

Istre O, Hald K, Qvigstad E (2004) Multiple myomas treated with a temporary, noninvasive, Doppler-directed, transvaginal uterine artery clamp. J Am Assoc Gynecol Laparosc 11:273–276. doi:10.1016/S1074-3804(05)60214-9 PubMedCrossRef

61.

Rasmussen J, Roberts HR, Astrup T (1964) Fibrinolytic activity of the normal and fibromyomatous human uterus. Surg Gynecol Obstet 118:1277–1280PubMed

62.

Pelage J-P, Cazejust J, Pluot E, Le Dref O, Laurent A, Spies JB, Chagnon S, Lacombe P (2005) Uterine fibroid vascularization and clinical relevance to uterine fibroid embolization. Radiographics 25(suppl 1):S99–S117. doi:10.1148/rg.25si055510 PubMedCrossRef

63.

Vilos GA (2007) Transvaginal Doppler-guided uterine artery occlusion for the management of leiomyomata uteri: initial pilot study results. J Minim Invasive Gynecol 14:S104. doi:10.1016/j.jmig.2007.08.162 Abstract 286CrossRef

64.

Lichtinger M, Burbank F, Hallson L, Herbert S, Uyeno J, Jones M (2003) The time course of myometrial ischemia and reperfusion after laparoscopic uterine artery occlusion—theoretical implications. J Am Assoc Gynecol Laparosc 10:553–566. doi:10.1016/S1074-3804(05)60168-5 CrossRef

65.

Park KH, Kim JY, Shin JS, Kwon JY, Koo JS, Jeong KA, Cho NH, Bai SW, Lee BS (2003) Treatment outcomes of uterine artery embolization and laparoscopic uterine artery ligation for uterine myoma. Yonsei Med J 44:694–702PubMed

66.

Burbank F (2004) Childbirth and myoma treatment by uterine artery occlusion: do they share a common biology? J Am Assoc Gynecol Laparosc 11:138–152. doi:10.1016/S1074-3804(05)60189-2 PubMedCrossRef

67.

Vilos GA, Hollett-Caines J, Burbank F (2006) Uterine artery occlusion: what is the evidence? Clin Obstet Gynecol 49:798–810. doi:10.1097/01.grf.0000211950.74583.f5 PubMedCrossRef

Titel: Treatment of fibroids via uterine artery occlusion (uterine artery embolization and Doppler-guided uterine artery occlusion): potential role in today’s armamentarium
verfasst von: Andrew I. Brill
Publikationsdatum: 01.10.2009
Verlag: Springer-Verlag
Erschienen in: Archives of Gynecology and Obstetrics / Ausgabe 4/2009
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-009-0952-0

Neu im Fachgebiet Gynäkologie und Geburtshilfe

20.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Treatment of fibroids via uterine artery occlusion (uterine artery embolization and Doppler-guided uterine artery occlusion): potential role in today’s armamentarium

Abstract

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Hochrisiko-Eingriffe für postoperative Übelkeit

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Update Gynäkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2009

Adenocarcinoma arising from the respiratory ciliated epithelium in a benign cystic teratoma of the ovary

A case of nephrogenic diabetes insipidus caused by partial bilateral ureteral obstruction due to advanced stage ovarian carcinoma

Genetic counseling in a case of congenital hemivertebrae

Synchronous diagnosis of multiple tumours in a postmenopausal woman

Vaginal delivery after myomectomy: challenges and opportunities

A new technique for the diagnosis of fallopian tube patency by using hysteroscopy with ultrasound compared with hysterosalpingography in infertile women

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Hochrisiko-Eingriffe für postoperative Übelkeit

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Update Gynäkologie